English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/125868
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Histamine impairs midbrain dopaminergic development in vivo by activating histamine type 1 receptors

AuthorsEscobedo-Ávila, Itzel; Vargas-Romero, Fernanda; Molina-Hernández, Anayansi; López-González, Rodrigo; Cortés, Daniel ; Carlos, Juan A. de ; Velasco, Iván
KeywordsNeural stem cells
Midbrain development
Dopaminergic neurons
Ultrasound injections
Parkinson’s disease
Issue Date12-Aug-2014
PublisherBioMed Central
CitationMolecular Brain 7(1): 58 (2014)
Abstract[Background] Histamine (HA) regulates the sleep-wake cycle, synaptic plasticity and memory in adult mammals. Dopaminergic specification in the embryonic ventral midbrain (VM) coincides with increased HA brain levels. To study the effect of HA receptor stimulation on dopamine neuron generation, we administered HA to dopamine progenitors, both in vitro and in vivo.
[Results] Cultured embryonic day 12 (E12) VM neural stem/progenitor cells expressed transcripts for HA receptors H1R, H2R and H3R. These undifferentiated progenitors increased intracellular calcium upon HA addition. In HA-treated cultures, dopamine neurons significantly decreased after activation of H1R. We performed intrauterine injections in the developing VM to investigate HA effects in vivo. HA administration to E12 rat embryos notably reduced VM Tyrosine Hydroxylase (TH) staining 2 days later, without affecting GABA neurons in the midbrain, or serotonin neurons in the mid-hindbrain boundary. qRT-PCR and Western blot analyses confirmed that several markers important for the generation and maintenance of dopaminergic lineage such as TH, Lmx1a and Lmx1b were significantly diminished. To identify the cell type susceptible to HA action, we injected embryos of different developmental stages, and found that neural progenitors (E10 and E12) were responsive, whereas differentiated dopaminergic neurons (E14 and E16) were not susceptible to HA actions. Proliferation was significantly diminished, whereas neuronal death was not increased in the VM after HA administration. We injected H1R or H2R antagonists to identify the receptor responsible for the detrimental effect of HA on dopaminergic lineage and found that activation of H1R was required.
[Conclusion] These results reveal a novel action of HA affecting dopaminergic lineage during VM development.
Publisher version (URL)http://dx.doi.org/10.1186/s13041-014-0058-x
URIhttp://hdl.handle.net/10261/125868
DOI10.1186/s13041-014-0058-x
ISSN1756-6606
Appears in Collections:(IC) Artículos
Files in This Item:
File Description SizeFormat 
13041_2014_Article_58.pdf3,43 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.